SCHEMBL5409453

SCHEMBL5409453

CC(C(=O)NCCCCCC(=O)ON1C(=O)CCC1=O)c1cc(/N=N/c2ccccc2C(=O)O)ccc1O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
NPSR1 Q6W5P4 4/20 0.44
MAPT P10636 3/20 0.44
GAA P10253 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
IDE P14735 1/20 0.35
HDAC3 O15379 2/20 0.34
HDAC4 P56524 2/20 0.34
HDAC1 Q13547 2/20 0.34
HDAC7 Q8WUI4 2/20 0.34
HDAC2 Q92769 2/20 0.34
HDAC10 Q969S8 2/20 0.34
HDAC11 Q96DB2 2/20 0.34
HDAC8 Q9BY41 2/20 0.34
HDAC6 Q9UBN7 2/20 0.34
HDAC9 Q9UKV0 2/20 0.34
HDAC5 Q9UQL6 2/20 0.34
MYC P01106 1/20 0.33
TDP1 Q9NUW8 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7129511 0.92 MEN1 (0.45) MEN1KMT2ANPSR1MAPTGAA
SCHEMBL5418551 0.85 MEN1 (0.50) MEN1KMT2ANPSR1MAPTGAA
SCHEMBL5409457 0.83 GAA (0.43) MEN1KMT2ANPSR1MAPTGAA
SCHEMBL5409463 0.83 GAA (0.43) MEN1KMT2ANPSR1MAPTGAA
SCHEMBL6808674 0.83 MEN1 (0.51) MEN1KMT2ANPSR1MAPTGAA
SCHEMBL6806511 0.82 MEN1 (0.47) MEN1KMT2ANPSR1MAPTGAA
SCHEMBL5425082 0.82 MEN1 (0.50) MEN1KMT2ANPSR1MAPTGAA
SCHEMBL6808385 0.82 MEN1 (0.52) MEN1KMT2ANPSR1MAPTGAA
SCHEMBL6812525 0.78 MEN1 (0.43) MEN1KMT2ANPSR1MAPTGAA
SCHEMBL6808391 0.76 MEN1 (0.49) MEN1KMT2ANPSR1MAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6602987-B1 4'-hydroxyazobenzene-2-carboxylic acid (HABA) compounds; useful as reagents for labeling, isolation and detection of biological molecules YEDA RESEARCH AND DEVELOPMENT CO., LTD. (IL) 2003-08-05 US claimed
US-7217575-B2 Avidin derivatives and uses thereof YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2007-05-15 US disclosed
US-20040191832-A1 Avidin derivatives and uses thereof YEDA RESEARCH AND DEVELOPMENT CO., LTD. 2004-09-30 US disclosed
US-20040067229-A1 Azobenzene derivatives as labeling agents and intermediates thereof YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2004-04-08 US disclosed
US-6632929-B1 Conjugate with 4'-hydroxyazobenzene-2-carboxylic acid derivative; change from red to yellow upon binding biotin YEDA RESEARCH AND DEVELOPMENT CO. LTD (IL) 2003-10-14 US disclosed
US-6602987-B1 4'-hydroxyazobenzene-2-carboxylic acid (HABA) compounds; useful as reagents for labeling, isolation and detection of biological molecules YEDA RESEARCH AND DEVELOPMENT CO., LTD. (IL) 2003-08-05 US disclosed
WO-2000027813-A1 AZOBENZENE DERIVATIVES AS LABELING AGENTS AND INTERMEDIATES THEREOF YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2000-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040067229-A1 Azobenzene derivatives as labeling agents and intermediates thereof CBR1, CBR3, HBB MEN1 2043/4885KMT2A 1572/4885NPSR1 593/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.